Skip to content

NUTRIRES2

Effect of the consumption of beef with different composition of fatty acids, in the anthropometric measurements of volunteers under a personalized diet. - NUTRIRES2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000403
Enrollment
28
Registered
2022-03-31
Start date
2022-05-16
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

Group A (Experimental): 120 g of beef of specialized sale with a high content of monounsaturated fatty acids (breed Wagyu-cross) fourth days a week for fourth weeks, prohibited consuming pork, fish, s

Sponsors

Genomic Biotechnology Center – National Polytechnic Institute (IPN-Reynosa), Mexico
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age between 25 and 55 years. 2. Body mass index (BMI) = 18.5 kg/m2 and less than 45 kg/m2. 3. Consume beef. 4. With a desire of lose weight and/or learn healthy eating habits. 5. Sign volunteer's written informed consent.

Exclusion criteria

Exclusion criteria: 1. Type 1 or type 2 diabetes. 2. Hypertension (defined as systolic blood pressure =140 or diastolic blood pressure = 90 mmHg). 3. Chronic diseases (of the hepatic, renal and cardiovascular systems, pancreatitis or some type of malignancy condition) or acute at the time of inclusion. 4. Alcoholism and/or drug dependence. 5. Smoker (> 10 cigarettes a day). 6. Women who are pregnant or breastfeeding. 7. Medicine consumption of or dietary supplements. 8. The volunteer no longer wishes to be part of the study. 9. Inability to comply with the instructions of the investigation.

Design outcomes

Primary

MeasureTime frame
Anthropometric measurements and indexs. Measurement time: At baseline, at 2 and 4 weeks. Weight (in Kg) Measurement time: At baseline, at 2 and 4 weeks. Waist circumference (in cm). Measurement time: At baseline, at 2 and 4 weeks Abdominal circumference (in cm). Measurement time: At baseline, at 2 and 4 weeks. Hip circumference (in cm). Measurement time: At baseline, at 2 and 4 weeks Waist-hip ratio (waist circumference/hip circumference in cm). Measurement time: At baseline, at 2 and 4 weeks Body Mass Index-BMI (Weight/(Height*Height). (Weight measured in Kg and height in m). Measurement time: At baseline, at 2 and 4 weeks

Secondary

MeasureTime frame
Cholesterol, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. Triglycerides, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. HDL-c, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. LDL-c, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. VLDL-C, (value in mg/dL). Measurement time: at baseline (time 0), and at 4 weeks. Atherogenic index, measurement time: at baseline (time 0), and at 4 weeks.

Countries

Mexico

Contacts

Public ContactDiana Vela Vasquez

Genomic Biotechnology Center – National Polytechnic Institute

diana.w@outlook.com

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Apr 4, 2026